Solvay Pharmaceuticals [clinicaltrials_resource:3a11f4e03d58070eaae85759dfeab5aa]
Global Clinical Director Solvay [clinicaltrials_resource:1cea9d1f57a6e3b7131344343c5d5445]Ingrid Meuwsen [clinicaltrials_resource:22c72378ae6bb3e7e43e030d6926d41e]Michel Conte [clinicaltrials_resource:6297337422d2311d1d98a9c29d600caa]Robyn Bethany [clinicaltrials_resource:812316d178624898d25edfa850b0d722]Claire Nee [clinicaltrials_resource:a74d498400ed86930420739ea536a4dc]Toshiaki Yamaguchi [clinicaltrials_resource:e262f223397c3ea7181e786aa419692f]
affiliation [clinicaltrials_vocabulary:affiliation]
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache [clinicaltrials:NCT00123201]Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia [clinicaltrials:NCT00139906]Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder [clinicaltrials:NCT00139919]To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox [clinicaltrials:NCT00141479]PK Effects of Bifeprunox & Valproate in Bipolar I [clinicaltrials:NCT00141505]Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism [clinicaltrials:NCT00193661]Pharmacokinetic Evaluation of Testosterone Gel (1%) [clinicaltrials:NCT00193700]clinicaltrials:NCT00347425clinicaltrials:NCT00396214BMS-646256 in Obese and Overweight Type 2 Diabetics [clinicaltrials:NCT00541567]clinicaltrials:NCT00568009First in Man Study With SLV341 [clinicaltrials:NCT00887445]
collaborator [clinicaltrials_vocabulary:collaborator]
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache [clinicaltrials:NCT00123201]Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects [clinicaltrials:NCT00126022]Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects [clinicaltrials:NCT00126061]Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects [clinicaltrials:NCT00126074]Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease [clinicaltrials:NCT00134251]Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia [clinicaltrials:NCT00139906]Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder [clinicaltrials:NCT00139919]To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox [clinicaltrials:NCT00141479]Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes [clinicaltrials:NCT00141492]PK Effects of Bifeprunox & Valproate in Bipolar I [clinicaltrials:NCT00141505]The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women [clinicaltrials:NCT00141544]The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women [clinicaltrials:NCT00141557]Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women [clinicaltrials:NCT00141570]Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women [clinicaltrials:NCT00145522]Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure [clinicaltrials:NCT00160134]Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type [clinicaltrials:NCT00160147]Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes [clinicaltrials:NCT00160160]Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy [clinicaltrials:NCT00160186]clinicaltrials:NCT00160199Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension [clinicaltrials:NCT00160212]Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension [clinicaltrials:NCT00160225]Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy [clinicaltrials:NCT00160238]Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women [clinicaltrials:NCT00160264]Efficacy and Safety of Moxonidine in Indian Patients [clinicaltrials:NCT00160277]Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures [clinicaltrials:NCT00160290]Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination [clinicaltrials:NCT00160316]Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes [clinicaltrials:NCT00160342]Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism [clinicaltrials:NCT00193661]Bifeprunox in the Treatment of Schizophrenia [clinicaltrials:NCT00193687]Pharmacokinetic Evaluation of Testosterone Gel (1%) [clinicaltrials:NCT00193700]Bifeprunox in the Treatment of Schizophrenia [clinicaltrials:NCT00193713]Patient-reported Outcomes in the Treatment of Schizophrenia [clinicaltrials:NCT00230828]A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis [clinicaltrials:NCT00244452]Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination [clinicaltrials:NCT00251082]Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis) [clinicaltrials:NCT00264225]Efficacy of Pancrelipase on Postprandial Belching and Bloating. [clinicaltrials:NCT00266721]SLV308 for Treatment of Patients With Early Parkinson's Disease [clinicaltrials:NCT00269516]Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China [clinicaltrials:NCT00325260]An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients [clinicaltrials:NCT00332917]SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease [clinicaltrials:NCT00335166]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Claire Nee, Solvay Pharmaceuticals [clinicaltrials_resource:11e26dbd4b41c438dda53cdf5234a190]Michel Conte, Solvay Pharmaceuticals [clinicaltrials_resource:16713bf77617a90fd9ec47b333b3f3be]Ellis Ides, Solvay Pharmaceuticals [clinicaltrials_resource:2a21d015b8406b6f4012b2ea2b3cfbbd]Erik van Leeuwen, Solvay Pharmaceuticals [clinicaltrials_resource:381529a13723bb4d77507fe93e0a7618]Veronika von Hahn, Solvay Pharmaceuticals [clinicaltrials_resource:3a7083e5aa5fc89f91d41b5d34090c9b]Cindy Lane, Solvay Pharmaceuticals [clinicaltrials_resource:4f3c99c28bbcab785fd1fa4c5988af26]Djenane Bennett, Solvay Pharmaceuticals [clinicaltrials_resource:537885c35eea45db88d63f57409fc10f]Martine Guy, Solvay Pharmaceuticals [clinicaltrials_resource:53ac5f61e8cb751dadeefd041dfddf86]Irene Grazioli, Solvay Pharmaceuticals [clinicaltrials_resource:54603c5b92341ef18be470e637d599cb]Joachim Luszick, Solvay Pharmaceuticals [clinicaltrials_resource:59e00b5f42bc2eec2bdc404fc340137a]Sheri Rhodes, Solvay Pharmaceuticals [clinicaltrials_resource:618f654315f3728c2340eea76493a0e4]Philippe Jais, Solvay Pharmaceuticals [clinicaltrials_resource:63e5518268d6677495db735d0ae6fc3e]Wil Cramer, Solvay Pharmaceuticals [clinicaltrials_resource:6a6c5f85ef115dd5020d63116df8dbda]Vickie Baranowski, Solvay Pharmaceuticals [clinicaltrials_resource:70e2bf5a7c5b108c1e834fdcd22fb6ef]Barbara Parker, Solvay Pharmaceuticals [clinicaltrials_resource:766ee76d8c16f355916c0ad2d87b8231]Joost Melis, Solvay Pharmaceuticals [clinicaltrials_resource:7f91d744ba6f812f4ce5a442325da747]Ellen van Kleef, Solvay Pharmaceuticals [clinicaltrials_resource:83f5815010ac8c050aa424c2612088b4]Loretta Stallings, Solvay Pharmaceuticals [clinicaltrials_resource:8b19bccc3140db79288ea2bee107f2b0]Maaike Cronenberg, Solvay Pharmaceuticals [clinicaltrials_resource:a195f405f53599922fcdc9728768802d]Kay-Christen Meyer, Solvay Pharmaceuticals [clinicaltrials_resource:a4a8607040f1ff49b9dd1ff17a6b4d1f]David Vilardell, Solvay Pharmaceuticals [clinicaltrials_resource:a982adc8ec8f1eb4eb2301d3a7bf891c]Jean-Claude Ansquer, Solvay Pharmaceuticals [clinicaltrials_resource:af2e919d34e5fee8f8adb92a4bd469f1]Jean Claude Ansquer, Solvay Pharmaceuticals [clinicaltrials_resource:b12eb84933eb7d74dda2df9d45a3c66d]Gereon Raddatz, Solvay Pharmaceuticals [clinicaltrials_resource:dd5d8d8019580d763a9e708773b7fdfb]Bruno Fraitag, Solvay Pharmaceuticals [clinicaltrials_resource:ee691258a9c6a2391760d2d723d3cefb]Gregor Eibes, Solvay Pharmaceuticals [clinicaltrials_resource:fd4deba10391d2a54fc8fbc3bbd474f8]
organization [clinicaltrials_vocabulary:organization]
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache [clinicaltrials:NCT00123201]Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects [clinicaltrials:NCT00126022]Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects [clinicaltrials:NCT00126061]Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects [clinicaltrials:NCT00126074]Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease [clinicaltrials:NCT00134251]Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia [clinicaltrials:NCT00139906]Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder [clinicaltrials:NCT00139919]To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox [clinicaltrials:NCT00141479]Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes [clinicaltrials:NCT00141492]PK Effects of Bifeprunox & Valproate in Bipolar I [clinicaltrials:NCT00141505]The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women [clinicaltrials:NCT00141544]The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women [clinicaltrials:NCT00141557]Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women [clinicaltrials:NCT00141570]Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women [clinicaltrials:NCT00145522]Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure [clinicaltrials:NCT00160134]Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type [clinicaltrials:NCT00160147]Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes [clinicaltrials:NCT00160160]Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy [clinicaltrials:NCT00160186]clinicaltrials:NCT00160199Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension [clinicaltrials:NCT00160212]Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension [clinicaltrials:NCT00160225]Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy [clinicaltrials:NCT00160238]Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women [clinicaltrials:NCT00160264]Efficacy and Safety of Moxonidine in Indian Patients [clinicaltrials:NCT00160277]Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures [clinicaltrials:NCT00160290]Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination [clinicaltrials:NCT00160316]Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes [clinicaltrials:NCT00160342]Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism [clinicaltrials:NCT00193661]Bifeprunox in the Treatment of Schizophrenia [clinicaltrials:NCT00193687]Pharmacokinetic Evaluation of Testosterone Gel (1%) [clinicaltrials:NCT00193700]Bifeprunox in the Treatment of Schizophrenia [clinicaltrials:NCT00193713]Patient-reported Outcomes in the Treatment of Schizophrenia [clinicaltrials:NCT00230828]A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis [clinicaltrials:NCT00244452]Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination [clinicaltrials:NCT00251082]Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis) [clinicaltrials:NCT00264225]SLV308 for Treatment of Patients With Early Parkinson's Disease [clinicaltrials:NCT00269516]Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in China [clinicaltrials:NCT00325260]An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients [clinicaltrials:NCT00332917]SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease [clinicaltrials:NCT00335166]An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients [clinicaltrials:NCT00335374]
source [clinicaltrials_vocabulary:source]
Solvay Pharmaceuticals [clinicaltrials_resource:3a11f4e03d58070eaae85759dfeab5aa]
Bio2RDF identifier
3a11f4e03d58070eaae85759dfeab5aa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3a11f4e03d58070eaae85759dfeab5aa
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:3a11f4e03d58070eaae85759dfeab5aa
title
Solvay Pharmaceuticals
@en
type
label
Solvay Pharmaceuticals [clinicaltrials_resource:3a11f4e03d58070eaae85759dfeab5aa]
@en